Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

被引：0

作者：

Chengyu Shi ^{[1
]}

Ying Wang ^{[2
]}

Minjie Wu ^{[3
]}

Yu Chen ^{[1
]}

Fangzhou Liu ^{[2
]}

Zheyuan Shen ^{[3
]}

Yiran Wang ^{[1
]}

Shaofang Xie ^{[2
]}

Yingying Shen ^{[3
]}

Lingjie Sang ^{[1
]}

Zhen Zhang ^{[2
]}

Zerui Gao ^{[3
]}

Luojia Yang ^{[1
]}

Lei Qu ^{[2
]}

Zuozhen Yang ^{[3
]}

Xinyu He ^{[4
]}

Yu Guo ^{[5
]}

Chenghao Pan ^{[1
]}

Jinxin Che ^{[6
]}

Huaiqiang Ju ^{[7
]}

Jian Liu ^{[1
]}

Zhijian Cai ^{[1
]}

Qingfeng Yan ^{[1
]}

Luyang Yu ^{[1
]}

Liangjing Wang ^{[1
]}

Xiaowu Dong ^{[1
]}

Pinglong Xu ^{[1
]}

Jianzhong Shao ^{[5
]}

Yang Liu ^{[4
]}

Xu Li ^{[5
]}

Wenqi Wang ^{[5
]}

Ruhong Zhou ^{[8
]}

Tianhua Zhou ^{[9
]}

Aifu Lin ^{[7
]}

机构：

[1] Zhejiang University,MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences

[2] Zhejiang University,Cancer Center

[3] Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Innovation Institute for Artificial Intelligence in Medicine

[4] Zhejiang University,Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences

[5] Zhejiang University,Key Laboratory of Structural Biology of Zhejiang Province, Westlake Laboratory of Life Sciences and Biomedicine

[6] Westlake University,Institute of Immunology

[7] Zhejiang University School of Medicine,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[8] Sun Yat-sen University Cancer Center,MOE Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute

[9] State Key Laboratory of Oncology in South China,Department of Developmental and Cell Biology

[10] Collaborative Innovation Center for Cancer Medicine,Shanghai Institute for Advanced Study

[11] Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute),Department of Chemistry

[12] Zhejiang University School of Medicine,Institute of Quantitative Biology

[13] International Campus,Department of Cell Biology and Program in Molecular Cell Biology

[14] Zhejiang University,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[15] Zhejiang University,Breast Center of the First Affiliated Hospital, School of Medicine

[16] Zhejiang University,International School of Medicine, International Institutes of Medicine

[17] University of California,undefined

[18] Zhejiang University,undefined

[19] Colombia University,undefined

[20] Zhejiang University,undefined

[21] Zhejiang University School of Medicine,undefined

[22] Zhejiang University,undefined

[23] Zhejiang University,undefined

[24] The 4th Affiliated Hospital of Zhejiang University School of Medicine,undefined

[25] ZJU-QILU Joint Research Institute,undefined

来源：

Nature Communications | / 15卷 / 1期

关键词：

D O I：

10.1038/s41467-024-55049-5

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[11] PD-1 blockade: promoting endogenous anti-tumor immunity
Peggs, Karl S.
Quezada, Sergio A.
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1279 - 1282
[12] Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment
Daisuke Umezu
Nana Okada
Yukimi Sakoda
Keishi Adachi
Toshiyasu Ojima
Hiroki Yamaue
Masatoshi Eto
Koji Tamada
Cancer Immunology, Immunotherapy, 2019, 68 : 201 - 211
[13] Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment
Umezu, Daisuke
Okada, Nana
Sakoda, Yukimi
Adachi, Keishi
Ojima, Toshiyasu
Yamaue, Hiroki
Eto, Masatoshi
Tamada, Koji
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 201 - 211
[14] FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis (vol 28, pg 285, 2015)
Dahan, Rony
Sega, Emanuela
Engelhardt, John
Selby, Mark
Korman, Alan J.
Ravetch, Jeffrey V.
CANCER CELL, 2015, 28 (04) : 543 - 543
[15] S-allylmercaptocysteine promotes anti-tumor immunity by suppressing PD-L1 expression
Zhao, Zhongxi
Wei, Guangwei
Zhao, Jianxiong
Sun, Yueyue
Gao, Peng
BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
[16] Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
Luo, Lianxiang
Wu, Tong
Ji, Miaorong
Xiang, Jing
Zou, Youwen
Liao, Yinglin
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
[17] BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Zhu, Hengrui
Bengsch, Fee
Svoronos, Nikolaos
Rutkowski, Melanie R.
Bitler, Benjamin G.
Allegrezza, Michael J.
Yokoyama, Yuhki
Kossenkov, Andrew V.
Bradner, James E.
Conejo-Garcia, Jose R.
Zhang, Rugang
CELL REPORTS, 2016, 16 (11): : 2829 - 2837
[18] MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity
Xiong, Wei
Deng, Huanghao
Huang, Changkun
Zen, Chong
Jian, Chengzhu
Ye, Kun
Zhong, Zhaohui
Zhao, Xiaokun
Zhu, Liang
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (02): : 454 - 463
[19] Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade
Jiang, Yuying
Yang, Yongbing
Hu, Yingchao
Yang, Rui
Huang, Jiajia
Liu, Yi
Wu, Yuqing
Li, Sheng
Ma, Chunmei
Humphries, Fiachra
Wang, Bingwei
Wang, Xi
Hu, Zhibin
Yang, Shuo
CELL REPORTS, 2022, 41 (04):
[20] A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity
Luan, Yan
Chai, Dafei
Peng, Jianjian
Ma, Shuli
Wang, Min
Ma, Hui
Li, Xiang
Fu, Shilong
Pan, Xiaolong
Wang, Xiaoxiao
Qin, Songbing
Xu, Ting
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 248 - 256

← 1 2 3 4 5 →